Clinical trial · Observational
Outcome of Treating Bladder Cancer in Sohag University Hospital
Outcome of Treating Urinary Bladder Cancer in Sohag University Hospital Between 2016 to 2020
NCT05082818CI-TRIAL-00059080completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Retrospective study of outcome of urinary bladder cancer treated in Sohag University hospital in the past 5 years from 2016 to 2020
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bladder Cancer | Malignant Bladder Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Chemotherapy, Radiotherapy and surgery | Combination Product | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Disease free survival
- timeFrame
- 2 weeks after treatment to the time of relapse
- description
- Time from the end of treatment to the date of first relapse
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * all stages and grades of urinary bladder cancer Any histological types of urinary bladder cancer Exclusion Criteria: * presence of other malignancies
References
Publications (0)
Data not yet available
No reference posted for this study.